Not knowing your test results can be more stressful than actually having a confirmed diagnosis, according to a study presented Nov. 29 at the RSNA annual conference. The uncertainty patients experience in the waiting room is as serious a stressor as knowing they have a malignant disease, the researchers found.
Not knowing your test results can be more stressful than actually having a confirmed diagnosis, according to a study presented Nov. 29 at the RSNA annual conference. The uncertainty patients experience in the waiting room is as serious a stressor as knowing they have a malignant disease, the researchers found.
“We found this uncertainty is one of the most challenging parts, because once you know what the diagnosis is, you can plan,” said lead author Dr. Elvira Lang, an associate professor of radiology at Harvard Medical School. “Psychologically, that is much easier to bear than hanging in the air.”
There really is no such thing as just a diagnostic test, she said. The uncertainty is more stressful than awaiting risky treatment, she said.
Lang and her colleague, Nicole Flory, Ph.D., studied stress levels in 214 women scheduled for different diagnostic and treatment procedures. They measured stress and anxiety levels with four standardized tests: the State Trait Anxiety Inventory, Impact of Events Scale, Center for Epidemiological Studies Depression Scale, and Perceived Stress Scale.
The study found the patients who were most stressed were the 112 women awaiting breast biopsy. They had an average score of 48 out of 80 on the State Trait Anxiety Inventory, where patients rate their comfort level while waiting for a procedure.
The 42 women awaiting hepatic chemoembolization for liver cancer had an average score of 26, while the 60 awaiting uterine fibroid embolization for uterine myoma had an average score of 24.
“The women who came for diagnosis of breast cancer were significantly more stressed than even women who came in for chemoembolization,” Lang said.
Scores for the other three standardized tests weren’t much different, with the highest stress ratings coming from breast biopsy patients.
While the study sampled only women, men experience the same anxiety, Lang said.
“There are similar models published on the effect of stress hormones for men undergoing prostate biopsy,” she said. “For men, if they don’t know what the diagnosis is, they are more stressed than if they are told they have cancer.”
Lang said the good news is that doctors can learn to alleviate the stress of patients coming in for diagnostic procedures by using language that is more helpful for the patient and frames the experience in a better way.
“Don’t give negative suggestions like, ‘This hurts,’ ‘It’s gonna sting,’ ‘It’s not that bad.’ That is the one thing we published that gives patients more pain and more anxiety,” Lang said.
Since concluding the study, Lang started a company that coaches professionals and patients in dealing with anxiety associated with diagnostic tests. She also wrote a book, Patient sedation without medication, on the subject.
AI Facilitates Nearly 83 Percent Improvement in Turnaround Time for Fracture X-Rays
December 19th 2023In addition to offering a 98.5 percent sensitivity rate in diagnosing fractures on X-ray, an emerging artificial intelligence (AI) software reportedly helped reduce mean turnaround time on X-ray fracture diagnosis from 48 hours to 8.3 hours, according to new research presented at the Radiological Society of North America (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can an Emerging PET Radiotracer Enhance Detection of Prostate Cancer Recurrence?
December 14th 2023The use of 68Ga-RM2 PET/MRI demonstrated a 35 percent higher sensitivity rate than MRI alone for the diagnosis of biochemical recurrence of prostate cancer, according to research recently presented at the Radiological Society of North America (RSNA) conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Can AI Improve Detection of Extraprostatic Extension on MRI?
December 4th 2023Utilizing a deep learning-based AI algorithm to differentiate between diagnostic and non-diagnostic quality of prostate MRI facilitated a 10 percent higher specificity rate for diagnosing extraprostatic extension on multiparametric MRI, according to research presented at the recent RSNA conference.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.